21-year-old creates safe space for people living with HIV
HIV activist and founder of HIV Plus Us campaign, Ibanomonde Ngema, has courageously shared her HIV status with the public while establishing a campaign as a beacon of hope and support for those affected.
At the age of seven, Ibanomonde Ngema's life took a turn when her mother and grandmother revealed her HIV diagnosis. Though she was too young to grasp the complexities of the illness, their sombre expressions and her instinctive tears hinted at its gravity.
Years later, during life orientation classes in primary school, Ngema began to comprehend the realities of HIV, fortunate to have a supportive family with a medical background to guide her through the journey.
'As a teenager I'm fortunate to have friends who have accepted me for who I am and revoked my history. I generally don't care how people feel or see me because I have fully accepted my status. I understand why you wouldn't be friends with me, I understand why you might not want to touch me, I understand why you are stigmatising me, so when I say, 'I understand', I mean I can no longer be stigmatised,' said Ngema
This is where her HIV Plus Us campaign comes in. It aims to bridge the language gap. In an attempt to resonate with youths, the campaign encourages HIV-positive living and demystifies stigma.
The campaign targets young people who use social media, taking into consideration that not everyone has access to it, specially in rural areas.
'At the moment we're laying the groundwork, getting the name in people's minds, building a scroll-stopping presence online, and becoming a kind of holy grail for the 4,000 adolescent girls and young women who are newly infected with HIV every week.'
The campaign also aims to educate their parents on how to deal with HIV-positive youths.
'Parents need to be helped to reimagine what HIV is and what it is not. It's no longer a death sentence. It's no longer something to hide in silence. If we want young people to live with HIV unapologetically, we need the adults around them to unlearn shame too.'
Ngema spoke about the importance of self-love when it comes to dating for people living with HIV and how people need to earn the right to access their vulnerability.
'I always tell young people, specially girls, to be brave, not desperate. If someone walks away after you disclose, that's not a reflection of your worth. It's only information to them. Let's not confuse rejection with truth.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Citizen
3 hours ago
- The Citizen
Measles outbreak in Gauteng: 181 cases confirmed, public urged to vaccinate
The Gauteng Department of Health has intensified its public health response following further measles cases across the province. Between January 1 and June 13, 181 laboratory-confirmed measles cases were reported, primarily in Johannesburg, Tshwane, and Ekurhuleni. In the latest reporting period, Gauteng recorded 15 new measles cases. Local nurse Nhlanhla Mofokeng explained what measles is and how to curb its spread. She defined measles as a highly contagious viral infection that mainly affects children but can infect anyone who is unvaccinated. 'It spreads through droplets in the air when an infected person coughs, sneezes, or talks. Measles symptoms appear about seven to 14 days after exposure,' she said. Signs and symptoms: • High fever; • Dry cough; • Runny nose; • Red, watery eyes; • Tiny white spots inside the mouth (Koplik spots); • A blotchy red rash that usually starts on the face and spreads downward. 'A person is contagious four days before and four days after the rash appears. Many people assume measles is just a rash and fever, but it can lead to severe complications,' she added. She mentioned these complications: • Pneumonia; • Diarrhoea and dehydration; • Ear infections (which might lead to hearing loss); • Brain swelling (encephalitis); • Death, especially in malnourished children or those with weakened immune systems. 'Children under five years, unvaccinated people of any age, people with weakened immune systems (HIV+ individuals) and pregnant women are at risk of contracting measles. 'Prevention is always better than cure. The measles vaccine is safe and free at public clinics across SA. It is given as part of the Measles, Mumps, and Rubella vaccine (MMR) at six months (extra dose during outbreaks), 12 months and 18 months,' she mentioned. Mofokeng said vaccination is the best protection because if enough people are vaccinated, the virus cannot spread; this is called herd immunity. She added that during the outbreak, people must ensure children are vaccinated by checking their Road-to-Health card. The nurse advised adults unsure of their vaccination status to visit a clinic for advice. 'If your child shows symptoms, keep them at home and visit a health facility immediately. Inform your school or crèche if a child was diagnosed. They may need to take steps to prevent further spread,' said Mofokeng. What to do if you suspect measles? • Step one: Seek medical care immediately; early detection can prevent serious illness. • Step two: Isolate the patient to avoid spreading the virus to others. • Step three: Follow the instructions from your clinic or doctor. ALSO READ: SASSA announces August payment dates for all social grants ALSO READ: Two arrested in Kwa-Thema for house robbery and possession of unlicensed firearms
Daily Maverick
20 hours ago
- Daily Maverick
Rethinking HIV treatment with tailored solutions for improved patient engagement and outcomes
The health department has R622-million extra to prop up South Africa's HIV treatment programme in the wake of foreign aid cuts. But it's only about a fifth of the total gap. We look at how data can help drive decisions to make the most of this lifebuoy. Just over two weeks ago, Health Minister Aaron Motsoaledi announced that the Treasury had given R622-million of emergency funding to his department to prop up South Africa's HIV treatment programme, with about R590-million for provinces' HIV budgets and R32-million for the chronic medicine distribution system, which allows people to fetch their antiretroviral treatment from pick-up points other than clinics, closer to their homes. This extra budget is just over a fifth of the roughly R2.8-billion funding gap that the health department says the country needed after US President Donald Trump's administration pulled the plug on financial support for HIV in February. (The Pepfar/Aids relief budget for this financial year was just under R8-billion, but the health department calculated that it could fill the void with R2.8-billion if it trimmed extras and ruled out duplicate positions.) So, how to get the best bang for these limited bucks — especially with the health department wanting to get 1.1-million people with HIV on treatment before the end of the year and so reach the United Nations targets for ending Aids as a public health threat by 2030? By getting really serious about giving people more than one way of getting their repeat prescriptions for antiretroviral (ARV) medicine (so-called differentiated service delivery), said Kate Rees, the co-chairperson of the 12th South African Aids Conference to be held later this year, from Kigali last week, where she attended the 13th IAS Conference on HIV Science. At another Kigali session, Lynne Wilkinson, a public health expert working with the health department on public health approaches to help people stay on treatment, said: 'People who interrupt their antiretroviral treatment are increasingly common, but so are people who re-engage, or in other words start their treatment again after having stopped for a short period.' A big part of South Africa's problem in getting 95% of people who know they have HIV on ARVs (the second target of the UN's 95-95-95 set of cascading goals) is that people — sometimes repeatedly — stop and restart treatment. For the UN goals to be reached, South Africa needs to have 95% of people diagnosed with HIV on treatment. Right now, the health department says, we stand at 79%. But the way many health facilities are run makes the system too rigid to accommodate real life stop-and-start behaviour, says Rees. This not only means that extra time and money are spent every time someone seemingly drops out of line and then comes back in, but also makes people unwilling to get back on board because the process is so inconvenient and unwelcoming. Rees and Wilkinson were the co-authors of a study published in the Journal of the International Aids Society in 2024, whose results helped the health department update the steps health workers should follow when someone has missed an appointment for picking up their medicine or getting a health check-up — and could possibly have stopped treatment. 'We often have excellent guidelines in place, built on solid scientific evidence,' says Rees, 'but they're not necessarily implemented well on the ground.' To make sure we track the second 95 of the UN goals accurately, we need a health system that acknowledges people will come late to collect their treatment and sometimes miss appointments. This doesn't necessarily mean they've stopped their treatment; rather that how they take and collect their treatment changes over time. 'The standard ways in which the public health system works mostly doesn't provide the type of support these patients need, as the resources required to provide such support is not available,' says Yogan Pillay, the health department's former deputy director-general for HIV and now the head of HIV delivery at the Gates Foundation. 'But with AI-supported digital health solutions and the high penetration of mobile phones, such support now can — and should — be provided at low cost and without the need to hire additional human resources.' We dived into the numbers to see what the study showed — and what they can teach us about making the system for HIV treatment more flexible. Does late equal stopped? Not necessarily. Data from three health facilities in Johannesburg that the researchers tracked showed that of the 2,342 people who came back to care after missing a clinic appointment for collection medication or a health check, 72% — almost three-quarters — showed up within 28 days of the planned date. In fact, most (65%) weren't more than two weeks late. Of those who showed up at their clinic more than four weeks after they were due, 13% made it within 90 days (12 weeks). Only one in 14 people in the study came back later than this, a period by which the health department would have recorded them as having fallen out of care. (Some incomplete records meant the researchers could not work out by how much 8% of the sample had missed their appointment date.) The data for the study was collected in the second half of 2022, and at the time national guidelines said that a medicine parcel not collected within two weeks of the scheduled appointment had to be sent back to the depot. 'But it's important to distinguish between showing up late and interrupting treatment,' notes Rees. Just because someone was late for their appointment doesn't necessarily mean they stopped taking their medication. Many people in the study said they either still had pills on hand or managed to get some, despite not showing up for their scheduled collection. Pepfar definitions say that a window of up to 28 days (that is, four weeks) can be tolerated for late ARV pick-ups. Pepfar is the US HIV programme that funds projects in countries like South Africa, but most of them were cut in February. Research has also shown that for many people who have been on treatment for a long time already, viral loads (how much HIV they have in their blood) start to pass 1,000 copies/mL — the point at which someone could start being infectious again — about 28 days after treatment has truly stopped. Sending back a parcel of uncollected medicine after just two weeks — as was the case at the time of the study — would therefore add an unnecessary administration load and cost into the system. (Current health department guidelines, updated since the study and in part because of the results, say that a medicine pick-up point can hold on to someone's medicine for four weeks after their scheduled appointment.) Does late equal unwell? Not always. In fact, seven out of 10 people who collected their next batch of medication four weeks or more late had no worrying signs, such as possible symptoms of tuberculosis, high blood pressure, weight loss or a low CD4 cell count, when checked by a health worker. (A low CD4 count means that someone's immune system has become weaker, which is usually a sign of the virus replicating in their body.) Moreover, given the large number of people without worrying health signs in the group for whom data was available, it's possible that many of those in the group with incomplete data were well too. When the researchers looked at the patients' last viral load results on file (some more than 12 months ago at the time of returning to the clinic), 71% had fewer than 1,000 copies/mL in their blood. A viral count of fewer than 1,000 copies/mL tells a health worker that the medicine is keeping most of the virus from replicating. It is usually a sign of someone being diligent about taking their pills and managing their condition well. Yet clinic staff often assume that people who collect their medicine late are not good at taking their pills regularly, and so they get routed to extra counselling about staying on the programme. 'Most people don't need more adherence counselling; they need more convenience,' says Rees. Offering services that aren't necessary because of an inflexible process wastes resources, she says — something a system under pressure can ill afford. Rees says: 'With funding in crisis, we really have to prioritise [where money is spent].' Does late equal indifferent? Rarely. Close to three-quarters of people who turned up four weeks or more after their scheduled medicine collection date said they had missed their appointment because of travelling, work commitments or family obligations. Only about a quarter of the sample missed their appointment because they forgot, misplaced their clinic card or for some other reason that would suggest they weren't managing their condition well. Part of making cost-effective decisions about how to use budgets best is to offer 'differentiated care', meaning that not every patient coming back after a missed appointment is treated the same way, says Rees. Health workers should look at by how much the appointment date was missed, as well as a patient's health status to decide what service they need, she says. Giving people who've been managing their condition well enough medicine to last them six months at a time can go a long way, Wilkinson told Bhekisisa's Health Beat team in July. 'Getting 180 pills in one go reduces the number of clinic visits [only twice a year], which eases the workload on staff. But it also helps patients to stay on their treatment by cutting down on their transport costs and time off work,' Wilkinson said. Zambia, Malawi, Lesotho and Namibia have all rolled out six-month dispensing — and have already reached the UN's target of having 95% of people on medicine at a virally suppressed level. According to the health department, South Africa will start rolling out six-month dispensing in August. 'But not everyone wants this,' said Wilkinson, pointing out that experiences from other countries showed that 50 to 60% of people choose six-monthly pick-ups. It speaks to tailoring service delivery to patients' needs, says Rees, rather than enforcing a one-size-fits-all system when more than one size is needed. Says Rees: 'Facing funding constraints, we really need tailored service delivery to keep the [HIV treatment] programme where it is.' DM
The Star
2 days ago
- The Star
South Africa boosts HIV funding amid global crisis affecting children and young women
Siphesihle Buthelezi | Published 2 weeks ago As the world faces a historic HIV funding crisis that threatens to reverse decades of progress, South Africa is emerging as a beacon of commitment, funding 77 percent of its national HIV response and pledging further increases in health and HIV spending over the next three years. According to UNAIDS' 2025 Global AIDS Update, released last week, South Africa's 2025 budget review includes a 5.9 percent annual increase in overall health expenditure and a 3.3 percent annual rise for HIV and tuberculosis programmes, along with plans to invest in health systems infrastructure, including a national chronic medicine dispensing system. But the report, titled 'AIDS, Crisis and the Power to Transform', warns that South Africa is an exception in a world where funding cuts are devastating HIV services, particularly for children and young women in low- and middle-income countries. In 2024, 620,000 children under 15 living with HIV did not receive treatment, leading to 75,000 AIDS-related child deaths. The year also saw 630,000 AIDS-related deaths globally, with 61 percent of them in sub-Saharan Africa. 'This is not just a funding gap: it's a ticking time bomb,' said UNAIDS Executive Director Winnie Byanyima. 'People, especially children and key populations, are being pushed out of care.' Adolescent girls and young women aged 15 to 24 are being hit especially hard. In 2024, over 210,000 acquired HIV, an average of 570 new infections every day. Prevention programmes that once protected this group are vanishing as donor funding disappears. In Nigeria, monthly PrEP (pre-exposure prophylaxis) initiation fell from 40,000 to just 6,000 people, while more than 60 percent of women-led HIV organisations surveyed in early 2025 had lost funding or shut down. In Mozambique, over 30,000 health personnel were affected by funding-related disruptions. If the crisis continues, UNAIDS estimates 6 million new HIV infections and 4 million AIDS-related deaths could occur between 2025 and 2029. While 25 countries have pledged domestic increases totalling 180 million US dollars in 2026, UNAIDS warns this is not enough to replace the large-scale donor withdrawals. Community-led services, crucial for reaching vulnerable populations, are being slashed, while new punitive laws in countries like Uganda and Mali are pushing people further from care. 'There is still time to transform this crisis into an opportunity,' said Byanyima. 'Countries are stepping up with domestic funding. Communities are showing what works. We now need global solidarity to match their courage and resilience.' 'In a time of crisis, the world must choose transformation over retreat,' she added. 'Together, we can still end AIDS as a public health threat by 2030 if we act with urgency, unity, and unwavering commitment.' THE MERCURY
